CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
The DIM-CriC project aims to develop a treatment for pancreatic ductal adenocarcinoma by synthesizing novel inhibitors that target inflammation linked to tumor growth. It focuses on enhancing the delivery of these inhibitors to assess their effectiveness against cancer-related inflammation.
We will develop and test a treatment for pancreatic ductal adenocarcinoma (PDAC).
To this aim, we will synthesize and evaluate the efficacy of novel inhibitors of nucleic acid-induced inflammation that we have identified.
Indeed, nucleic acid-induced chronic inflammation is a major driver of tumorigenesis.
Because the canonical pathway that triggers nucleic acid-induced chronic inflammation relies on the STING protein, identifying ways to activate or inhibit STING is a major goal of current rese…
CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE CNRS
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
France, Boulogne-Billancourt
Type: Company (for-profit)
Activity type: Private for-profit entities (excluding Higher or Secondary Education Establishments)
SME: No
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
